Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$27,000.00

Exploring the Role of Human Endogenous Retrovirus Expression in Accelerated Aging and Menopause in Women with Intellectual Disabilities

FY 2024-25

Summary
Human Endogenous Retroviruses (HERVs) are dormant retroviral DNA sequences embedded in the human genome. These viruses can be reactivated through epigenetic changes such as DNA methylation, which have significant health implications. Overexpression of HERVs has been linked to a variety of negative health outcomes, including autoimmune diseases, inflammation, cancer, and neurodegeneration. Additionally, HERVs can be reactivated as part of the aging process, potentially influencing age-related diseases. This is especially relevant for individuals with intellectual disabilities (ID) who experience accelerated aging. The purpose of this research is to investigate the relationship between HERV expression and its potential role in accelerated aging and premature menopause in women with ID. The study will also explore how early aging and premature menopause impact health-related quality of life, with a particular focus on cardiovascular health, as measured by heart rate variability (HRV). In this cross-sectional study, participants will be recruited from organizations in Calgary that support women with ID. Blood samples will be analyzed to assess HERV expression, while HRV will be used to evaluate age-related health outcomes. Ultimately, this research aims to determine whether HERV expression can serve as a more accurate measure of biological age, helping healthcare professionals and caregivers better track aging processes like menopause and implement timely and tailored interventions.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
529973
Name
Panech Anmol
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the Role of Human Endogenous Retrovirus Expression in Accelerated Aging and Menopause in Women with Intellectual Disabilities
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Accelerated Aging; Human Endogenous Retrovirus; Intellectual Disability; Menopause; Women'S Health
Abstract
Human Endogenous Retroviruses (HERVs) are dormant retroviral DNA sequences embedded in the human genome. These viruses can be reactivated through epigenetic changes such as DNA methylation, which have significant health implications. Overexpression of HERVs has been linked to a variety of negative health outcomes, including autoimmune diseases, inflammation, cancer, and neurodegeneration. Additionally, HERVs can be reactivated as part of the aging process, potentially influencing age-related diseases. This is especially relevant for individuals with intellectual disabilities (ID) who experience accelerated aging. The purpose of this research is to investigate the relationship between HERV expression and its potential role in accelerated aging and premature menopause in women with ID. The study will also explore how early aging and premature menopause impact health-related quality of life, with a particular focus on cardiovascular health, as measured by heart rate variability (HRV). In this cross-sectional study, participants will be recruited from organizations in Calgary that support women with ID. Blood samples will be analyzed to assess HERV expression, while HRV will be used to evaluate age-related health outcomes. Ultimately, this research aims to determine whether HERV expression can serve as a more accurate measure of biological age, helping healthcare professionals and caregivers better track aging processes like menopause and implement timely and tailored interventions.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Panech, Anmol
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~